CymitQuimica logo

CAS 817194-38-0

:

Formule :C19H16FN5O2
InChI :InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)
Code InChI :HEAIGWIZTYAQTC-UHFFFAOYSA-N
SMILES :CC1=C(C(NC(=O)N1)C2=CC=C(C=C2)F)C(=O)NC3=CC4=C(C=C3)NN=C4
6 produits trouvés.
  • 4-(4-Fluorophenyl)-N-(1H-Indazol-5-Yl)-6-Methyl-2-Oxo-1,2,3,4-Tetrahydropyrimidine-5-Carboxamide

    CAS :
    4-(4-Fluorophenyl)-N-(1H-Indazol-5-Yl)-6-Methyl-2-Oxo-1,2,3,4-Tetrahydropyrimidine-5-Carboxamide
    Formule :C19H16FN5O2
    Degré de pureté :99%
    Masse moléculaire :365.36

    Ref: 54-PC108993

    100mg
    185,00€
    250mg
    284,00€
  • GSK180736A

    CAS :
    GSK180736A
    Formule :C19H16FN5O2
    Degré de pureté :99.5%
    Masse moléculaire :365.36

    Ref: 54-BUP11975

    5mg
    98,00€
    10mg
    131,00€
    25mg
    238,00€
    50mg
    420,00€
    100mg
    764,00€
    500mg
    1.493,00€
  • GSK180736A

    CAS :
    Formule :C19H16FN5O2
    Degré de pureté :97%
    Couleur et forme :Solid
    Masse moléculaire :365.3610

    Ref: IN-DA01EO6R

    1mg
    50,00€
    5mg
    50,00€
    10mg
    60,00€
    50mg
    108,00€
  • GSK180736A

    CAS :
    GSK180736A: GRK2 inhibitor (IC50 0.77µM), >100x selectivity vs GRKs, weak at PKA (IC50 30µM), strong vs ROCK1 (IC50 100nM).
    Formule :C19H16FN5O2
    Degré de pureté :98.98% - 99.51%
    Couleur et forme :Solid
    Masse moléculaire :365.361
  • GSK180736A

    CAS :
    4-(4-Fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide
    Formule :C19H16FN5O2
    Degré de pureté :99%
    Masse moléculaire :365.36
  • GSK180736A

    CAS :

    GSK180736A is a potent and selective small-molecule inhibitor of the serine/threonine kinase PKCδ with in vitro IC50 values of 0.5 nM. GSK180736A inhibits the phosphorylation of PKCδ substrates by PKCδ and prevents its nuclear translocation, leading to inhibition of cardiac hypertrophy and insulin resistance. The IC50 value for inhibition of PKCδ activity was determined to be 0.5 nM in an internalization assay using cells expressing GFP-tagged human PKCδ (hPKCδ). In addition, GSK180736A inhibits the phosphorylation of PKCα and ε at a concentration of 1 μM in an in vitro kinase assay. These results suggest that GSK180736A is a selective inhibitor for the kinase domain of PKCδ and other members of the PKC family

    Formule :C19H16FN5O2
    Degré de pureté :Min. 95%
    Masse moléculaire :365.36 g/mol

    Ref: 3D-SHB19438

    50mg
    1.052,00€
    100mg
    1.463,00€